Stories Tagged as
Purdue Pharma
Art as commodity versus art as protest
by
Ellen Rolfes
Jun 24, 2023
Econ Extra Credit newsletter #155
Where will the opioids settlement money go?
by
Ellen Rolfes
Jun 16, 2023
Econ Extra Credit newsletter #154
Why the Sacklers are shielded from future opioids lawsuits
by
Ellen Rolfes
Jun 10, 2023
Econ Extra Credit newsletter #153
OxyContin maker Purdue Pharma to plead to 3 criminal charges
Oct 21, 2020
The drugmaker will also pay a settlement of more than $8 billion, the Justice Department announced Wednesday.
Companies reach $260 million deal to settle opioids lawsuit
Oct 21, 2019
The nation’s three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle an opioid crisis lawsuit just as the first federal trial over the crisis was due to begin.
Would a $10 billion Purdue settlement reach towns affected by the opioid crisis?
by
Kai Ryssdal
and Caitlin Esch
Aug 28, 2019
A proposed settlement would reportedly see the OxyContin maker declaring bankruptcy and paying big. Is that enough for people on the ground?
OxyContin maker Purdue Pharma to stop marketing opioids to doctors
Feb 10, 2018
Purdue’s promotions exaggerated the drug’s safety and risks of addiction, leaning heavily on one sentence used by sales reps to market the drug to doctors.
For public good, not for profit.
How one sentence helped set off the opioid crisis
by
Caitlin Esch
Dec 13, 2017
Recently unsealed documents shed light on how the maker of OxyContin seems to have relied more on focus groups than on scientific studies to create an aggressive and misleading marketing campaign that helped fuel the national opioid epidemic.
OxyContin's waiting game: Generic drug makers salivate while the FDA wants safer pills
Apr 16, 2013
OxyContin is supposed to come off patent and generic drug makers are excited. But, the FDA may put a stop to it all to wait for safer pills.